•  
  •  
  •  
  •  

2026-02-15 22:10:15

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • UVS Hospitality acquires 51% Stake in Calcio Restaurants via Share Swap and Capital Raise
  • Centum Electronics sharpens strategic focus and realigns Global Portfolio
  • HFCL Limited secures export order worth ~USD 4.67 Mn
  • RBI grants approval for Bain Capital to acquire joint control in Manappuram Finance
  • Anupam Rasayan Delivers Strong Q3 FY26 Performance

Keywords Selected:  Alpha

Stock Report

  • Alphalogic Industries Ltd wins order from Blink Commerce Pvt Ltd
  • Jagsonpal Pharmaceuticals Ltd Q3FY26 profit at Rs. 10.95 crores
  • Piramal Pharma Ltd consolidated Q2FY26 loss at Rs. 99.22 crores
  • Jagsonpal Pharmaceuticals Ltd Q2FY26 PAT up at Rs. 12.57 crores
  • NHPC updates on commissioning of 300 MW Grid Connected Solar PV Project in Bikaner, Rajasthan
  • Geomysore Services India Pvt Ltd Gold Mine Enters Pre-Commercial Phase
  • The Card Company collaborates with DreamFolks to launch India's First Premium Wallet
  • Alphageo Offshroe Services Pvt Ltd receives contract from Oil India Ltd
  • Piramal Pharma Solutions and NewAmsterdam Pharma announce dedicated OSD production Capabilities at Piramal's Sellersville, Pennsylvania Site
  • ONGC, BP Exploration Alpha Ltd and Reliance Industries Ltd Sign Joint Operating Agreement for Offshore Block in Saurashtra Basin
  • Piramal Pharma Ltd Q1 FY2025-26 consolidated loss at Rs. 81.70 crores
  • Jagsonpal Pharmaceuticals Ltd Q1 FY2025-26 net profit climbs to Rs. 10.79 crores
  • Lupin and Sino Universal Pharmaceuticals Sign License and Supply Agreement for Tiotropium DPI in China
  • Piramal Pharma Ltd completes USFDA inspection of Aurora facility with Zero Form-483 observations
  • Divi's Laboratories inks long term manufacturing and supply agreement with global pharma company
  • Piramal Pharma Limited recommends final dividend of Rs. 0.14
  • Piramal Pharma reports consolidated net profit of Rs. 153.50 crores in Q4 FY25
  • Jagsonpal Pharmaceuticals Limited recommends dividend of Rs. 2.5
  • Jagsonpal Pharmaceuticals Ltd Q4 FY2025 PAT slides QoQ to Rs. 6.58 crores
  • Divi's Laboratories signs long-term manufacturing and supply agreement with global pharma company
  • ZIM Laboratories Limited and Globalpharma Co. L.L.C. announce strategic collaboration to Commercialize Oral Thin Film Products in the GCC Region
  • Amneal Pharmaceuticals launches 2nd NDA Bortezomib for injection3.5mg/1.4ml in US
  • BrePco Biopharma and Piramal Critical Care announce MHRA approval for NeoatriconĀ® in the UK
  • US FDA Inspection at Piramal Pharma's facility located at Turbhe

Industry News

  • Ashika Investment Managers Launches SmartAlpha Fund, a New Open-Ended Category III Data Strategy Fund
  • Wundrsight raises USD 400K in a Seed Round led by Inflection Point Ventures
  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Mutual Funds

  • Edelweiss Mutual Fund launches the 'Nifty Alpha Low Volatility 30 Index Fund'

Latest Post

  • UVS Hospitality acquires 51% Stake in Calcio Restaurants via Share Swap and Capital Raise
  • Centum Electronics sharpens strategic focus and realigns Global Portfolio
  • HFCL Limited secures export order worth ~USD 4.67 Mn
  • RBI grants approval for Bain Capital to acquire joint control in Manappuram Finance
  • Anupam Rasayan Delivers Strong Q3 FY26 Performance


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025